Company Analysis Glaukos Corporation
1. Summary
Advantages
- The stock's return over the last year (76.65%) is higher than the sector average (-0.7555%).
- The company's current efficiency (ROE=-29.16%) is higher than the sector average (ROE=-80.86%)
Disadvantages
- Price (156.53 $) is higher than fair price (48.06 $)
- Dividends (0%) are below the sector average (1.31%).
- Current debt level 30.21% has increased over 5 years from 8.87%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Glaukos Corporation | Healthcare | Index | |
|---|---|---|---|
| 7 days | 2.4% | 2.4% | -0.4% |
| 90 days | 22.7% | -4.9% | 1.5% |
| 1 year | 76.6% | -0.8% | 21.8% |
GKOS vs Sector: Glaukos Corporation has outperformed the "Healthcare" sector by 77.4% over the past year.
GKOS vs Market: Glaukos Corporation has outperformed the market by 54.87% over the past year.
Stable price: GKOS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: GKOS with weekly volatility of 1.47% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (156.53 $) is higher than the fair price (48.06 $).
Price is higher than fair: The current price (156.53 $) is 69.3% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (57.87).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (47.68).
4.3. P/BV
P/BV vs Sector: The company's P/BV (8.64) is lower than that of the sector as a whole (9.39).
P/BV vs Market: The company's P/BV (8.64) is lower than that of the market as a whole (22.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (12.67) is higher than that of the sector as a whole (4.07).
P/S vs Market: The company's P/S indicator (12.67) is lower than that of the market as a whole (15.21).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-52.1) is lower than that of the sector as a whole (17.62).
EV/Ebitda vs Market: The company's EV/Ebitda (-52.1) is lower than that of the market as a whole (24.31).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 2.44% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (2.44%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-66.62%).
5.4. ROE
ROE vs Sector: The company's ROE (-29.16%) is higher than that of the sector as a whole (-80.86%).
ROE vs Market: The company's ROE (-29.16%) is lower than that of the market as a whole (18.08%).
5.5. ROA
ROA vs Sector: The company's ROA (-14.32%) is lower than that of the sector as a whole (6.71%).
ROA vs Market: The company's ROA (-14.32%) is lower than that of the market as a whole (6.49%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (-2.46%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (-2.46%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.31%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
8. Insider trades
8.1. Insider trading
Insider Selling More insider purchases by 450.03% over the last 3 months.
8.2. Latest transactions
| Transaction date | Insider | Type | Price | Volume | Quantity |
|---|---|---|---|---|---|
| 11.12.2024 | Kliman Gilbert H Director |
Sale | 144.01 | 288 020 | 2 000 |
| 11.12.2024 | Kliman Gilbert H Director |
Purchase | 32 | 64 000 | 2 000 |
| 09.09.2024 | Kliman Gilbert H Director |
Sale | 130.67 | 392 010 | 3 000 |
| 09.09.2024 | Kliman Gilbert H Director |
Purchase | 32 | 96 000 | 3 000 |
| 15.08.2024 | Stapley Marc Director |
Purchase | 125.93 | 787 063 | 6 250 |
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
